Back
Penumbra 10K Form
Buy
62
PEN
Penumbra
Last Price:
204.16
Seasonality Move:
-1.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-03 | 10Q | PEN/Penumbra Quarterly |
2020-05-07 | 10Q | PEN/Penumbra Quarterly |
2020-02-26 | 10K | PEN/Penumbra Annual |
2019-11-07 | 10Q | PEN/Penumbra Quarterly |
2019-08-06 | 10Q | PEN/Penumbra Quarterly |
2019-05-07 | 10Q | PEN/Penumbra Quarterly |
Receive PEN News And Ratings
See the #1 stock for the next 7 days that we like better than PEN
PEN Financial Statistics
Sales & Book Value
Annual Sales: | $1.06B |
---|---|
Cash Flow: | $18.08M |
Price / Cash Flow: | 72.12 |
Annual Sales: | $29.90 |
Price / Book: | 6.81 |
Profitability
EPS (TTM): | 0.34000 |
---|---|
Net Income (TTM): | $14.23M |
Gross Margin: | $682.64M |
Return on Equity: | 1.25% |
Return on Assets: | 0.94% |
Penumbra Earnings Forecast
Key Penumbra Financial Ratios
- The Gross Profit Margin over the past 12 years for PEN is 64.49%.
- The Selling, General & Administrative Expenses for PEN have been equal to 47.85% of Gross Profit Margin.
- The Research & Development expenses have been 7.98% of Revenue.
- The Interest Expense is 1.91% of Operating Income.
- The Net Earning history of PEN is 8.59% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Penumbra Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | PEN |
CUSIP: | 70975L |
Website: | penumbrainc.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 6.25 |
Quick Ratio: | 3.58 |
Price-to-Earnings
Trailing P/E Ratio: | 87.81 |
---|---|
Forward P/E Ratio: | 56.62 |